HUP0002236A2 - Solubilized sertraline compositions and process for their preparation - Google Patents

Solubilized sertraline compositions and process for their preparation

Info

Publication number
HUP0002236A2
HUP0002236A2 HU0002236A HUP0002236A HUP0002236A2 HU P0002236 A2 HUP0002236 A2 HU P0002236A2 HU 0002236 A HU0002236 A HU 0002236A HU P0002236 A HUP0002236 A HU P0002236A HU P0002236 A2 HUP0002236 A2 HU P0002236A2
Authority
HU
Hungary
Prior art keywords
preparation
compositions
solubilized
solubilized sertraline
sertraline compositions
Prior art date
Application number
HU0002236A
Other languages
Hungarian (hu)
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002236(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HUP0002236A2 publication Critical patent/HUP0002236A2/en
Publication of HUP0002236A3 publication Critical patent/HUP0002236A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány szertralint vagy ennek gyógyászatilag elfogadható sóját ésegy megfelelő mennyiségű oldódást elősegítő szert tartalmazókészítményre vonatkozik. A találmány kiterjed a készítményelőállítására is. ÓThe invention relates to a composition containing sertraline or a pharmaceutically acceptable salt thereof and an appropriate amount of a solubilizing agent. The invention also covers the production of the preparation. HE

HU0002236A 1997-07-01 1998-06-15 Solubilized sertraline compositions and process for their preparation HUP0002236A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
HUP0002236A2 true HUP0002236A2 (en) 2003-08-28
HUP0002236A3 HUP0002236A3 (en) 2003-12-29

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002236A HUP0002236A3 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions and process for their preparation

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (en) * 1989-08-30 1993-11-15 Pfizer USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EP0999829A1 (en) 2000-05-17
CO4940495A1 (en) 2000-07-24
EA199900962A1 (en) 2000-08-28
KR20010013365A (en) 2001-02-26
BR9810739A (en) 2000-09-12
AU7544898A (en) 1999-01-25
HN1998000102A (en) 1999-01-08
YU68299A (en) 2002-06-19
MA24587A1 (en) 1998-12-31
TNSN98124A1 (en) 2005-03-15
WO1999001120A1 (en) 1999-01-14
UY25071A1 (en) 2000-12-29
SK181099A3 (en) 2000-07-11
PL337804A1 (en) 2000-09-11
DZ2548A1 (en) 2003-02-08
CN1261794A (en) 2000-08-02
IS5260A (en) 1999-11-19
HRP980377A2 (en) 1999-04-30
IL133076A0 (en) 2001-03-19
PE97199A1 (en) 1999-10-05
NO996520D0 (en) 1999-12-28
AR040279A2 (en) 2005-03-23
AP1192A (en) 2003-07-23
PA8454301A1 (en) 2000-09-29
OA11243A (en) 2003-07-24
AR015917A1 (en) 2001-05-30
ZA985708B (en) 2000-01-10
IL133076A (en) 2003-12-10
EA002481B1 (en) 2002-06-27
AU742535B2 (en) 2002-01-03
AP9801280A0 (en) 1998-06-30
TR199903297T2 (en) 2000-07-21
KR100366373B1 (en) 2003-01-14
NO996520L (en) 2000-02-29
CA2290974A1 (en) 1999-01-14
TW550087B (en) 2003-09-01
AR040280A2 (en) 2005-03-23
BG103918A (en) 2000-07-31
UA67741C2 (en) 2004-07-15
ID23429A (en) 2000-04-20
HUP0002236A3 (en) 2003-12-29
JP2000514100A (en) 2000-10-24
CA2290974C (en) 2004-04-27

Similar Documents

Publication Publication Date Title
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
HUP9801240A2 (en) Oral compositions
SI1465626T1 (en) Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses
PL311122A1 (en) Water-solublederivatives of camptotectin, method of obtaining them and their application as anticarcinogenic agents
IL141157A0 (en) Salt form of pantoprazole and pharmaceutical compositions containing the same
MX9804588A (en) Use of halogen bleach-comprising compositions for improved mildness to the skin.
BG105302A (en) Means for improving cognition
TNSN98127A1 (en) AZETIDINYLPROPYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUP0001014A2 (en) Use of gastrointestinal lipase inhibitors
BG105197A (en) Polymorph form of a medicament
ZA965997B (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
HUP0002236A2 (en) Solubilized sertraline compositions and process for their preparation
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
HK1029937A1 (en) Use of phanquinone for the treatment of alzheimer s disease.
HUP0105308A2 (en) Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
UA48962C2 (en) Bicyclic antagonists of tachykinins, pharmaceutical composition and method of treatment
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
GB9015774D0 (en) Novel treatment
HUP9800835A3 (en) Pharmaceutical composition for treatment of diseases of honey-bees caused by ascophaera apis

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees